Highest quality biospecimen make all the difference

We are convinced that biospecimen quality along with the resulting data is crucial to making all relevant details of a cancer disease transparent. That’s why we apply numerous detailed standard operating procedures (SOPs) to the collection and processing of our wide variety of biospecimen and corresponding clinical data, achieving an ischemia time for tissue of ≤10 minutes and covering around 300 individual data points.


To ensure a constantly high quality of specimen and the highest level of comparability, all our clinical partners around the globe have implemented our detailed and in-depth SOPs. The procedures have been developed and refined through decades of experience working side-by-side with surgeons and pathologists in our network.

How it Works

We collect clinical data and biospecimen through collaborating partner clinics on three continents and in seven countries. Diversified ethnicities and entities on the one hand and uniform SOPs, a central research laboratory, and one cancer database on the other are unique and make Indivumed’s work so valuable.

Collection of Patient Data,
Tissue, and Fluid Samples

With our SOPs, the process is fully controlled throughout the workflow: from the time of resection to biosampling, clinical data review, and storage. Of course, we strictly adhere to the applicable data protection guidelines (GDPR).

Tissue is
the Issue

A minimum cold ischemia time of ≤10 minutes prevents false phosphorylation events in the tissue samples – going beyond that timeframe the quality loss increases dramatically.

Central Storage
in our Biobank

Some parts of the tissue are fresh frozen (FF) immediately at minus 165°C and other parts are fixated in formalin and embedded in paraffin (FFPE). The pseudonymized patient data are stored centrally with the biospecimen.

Collaborating with Indivumed Therapeutics

Would you like to become part of our Clinical Network? Are you interested in a collaborative partnership or a career at Indivumed? If so, we look forward to hearing from you.